ArticleThe Lancet regional health. Europe2024

Efficacy and safety of MP1032 plus standard-of-care compared to standard-of-care in hospitalised patients with COVID-19: a multicentre, randomised double-blind, placebo-controlled phase 2a trial.

Petra Sager et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.